Aclaris Therapts (ACRS) Stock Price, Quote & News

Company Profile

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States. The company product pipeline includes Bosakitug (ATI-045), an anti-thymic stromal lymphopoietin monoclonal antibody in Phase 2 trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease; ATI-2...

Industry: Biotechnology

Sector: Healthcare

Phone: 484 324 7933

Website: www.aclaristx.com

Address:

701 Lee Road, Suite 103, Wayne, United States

Acan1219 May. 14 at 12:55 AM

$ACRS Latest Overnight Price is Looking Spicy my Bull’s! Double Digits incoming! Imho..

0 · Reply

Acan1219 May. 13 at 8:58 PM

$ACRS Nope! Check those Charts again! Much Higher!

0 · Reply

OriginalTradeonrumor May. 13 at 7:21 PM

$ACRS be great to to close over $5!

0 · Reply

Puffyk May. 13 at 3:36 PM

$ACRS setting up nicely in preparation for presentation tomorrow. The pop to $15 is coming

0 · Reply

Acan1219 May. 13 at 1:48 PM

$ACRS Back to 5’s my Bull’s! Let’s Goooo!

0 · Reply

OfficialStocktwitsUser May. 12 at 2:22 PM

$ACRS RSI: 63.48, MACD: 0.2685 Vol: 0.31, MA20: 4.47, MA50: 3.97 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

OriginalTradeonrumor May. 11 at 1:59 PM

$ACRS hope everyone is enjoying the 5’s🥳

0 · Reply

Acan1219 May. 11 at 1:40 PM

$ACRS Big Moves Coming!

0 · Reply

Bionco May. 11 at 1:34 PM

$ACRS ACRS could continue to rally for the whole year.

0 · Reply

GreenEnergy1 May. 11 at 11:38 AM

$ACRS We’ve been with Aclaris for a very long time and have enjoyed a couple wild swings. This appears to be another good run. Don’t expect big news or any logic. ACRS drops and pops based on investor momentum, not actual data! Good luck all!

0 · Reply